Introduction
Influenza surveillance with genetic and antigenic characterization of virus isolates has become routine in many countries. Data and viruses submitted to the WHO's Global Influenza Surveillance and Response System (GISRS) from National Influenza Centers (NIC) provides an understanding of the global circulation of influenza viruses and is essential for vaccine strain selection. However, virus strains submitted to GISRS and strains selected for inclusion in Northern and Southern Hemisphere vaccines may not be globally representative. Although GISRS encourages representative and timely sharing of viruses, specimens from tropical countries are under-represented. There is, therefore, a need to increase the number of viruses submitted for analysis from tropical areas to better assess the relevance of the WHO recommended vaccine strains in tropical countries that are considering the introduction of influenza vaccination.
patients. 1, [6] [7] [8] [9] The National Influenza Surveillance System (NISS) was established in 2005 and comprises 15 sentinel sites (seven sites located in the Northern Region and eight surveillance sites located in the Southern, Highland, and Central Regions of Vietnam), and four regional laboratories. In global temperate regions, there are two flu season annually, corresponding to the occurrence of winter in the Northern and Southern Hemispheres, and influenza vaccination is delivered annually to protect against the influenza strains emergent during each winter influenza season. 2, 7, 8 Unlike those regions, the Hanoi-based surveillance from 2001 to 2006 and the first 5 years of national surveillance in Vietnam from 2006 to 2009 revealed two peaks of seasonal influenza transmission each year, as has been reported in neighboring tropical countries. 1, 3, 4, 6, 7, 10, 11 Vietnam is developing seasonal influenza vaccine manufacturing capacity, and the implementation of a rational influenza vaccination strategy requires information on the optimal timing and antigenic composition of the vaccine. 
Materials and methods

Ethical approval
The study was conducted as a part of the Vietnam Ministry of Health approved influenza surveillance system using samples taken from patients presenting to health care facilities with an ILI. The National Institute of Hygiene and Epidemiology and CDC, Atlanta provided ethical committee approval for the study. All participants provided written informed consent.
Sample collection
Patients of any age presenting to one of the sentinel sites (central hospitals, district hospitals, and polyclinics) with an ILI (measured fever ‡38°C and cough and ⁄ or sore throat) within 3 days of onset were eligible for inclusion. 1 Nasopharyngeal swabs (NPS) or throat swabs (TS) were collected by trained nurses using cotton swabs (Hanacomedical. CO.LTD -Japan). Swabs were stored in in-house viral transport media (VTM). 1, 7 In the sentinel sites in Hanoi, nasopharyngeal swabs (NPS) were collected from outpatients and specimens were transferred to the respiratory virus laboratory of NIHE on the day of collection 1, 2 .
At the 15 sentinel sites of the NISS, throat swabs were collected from the first two ILI patients each weekday (10 swabs per week ⁄ per sentinel site). 1 The TS were refrigerated in in-house VTM and transferred on Friday or on Monday of the following week on wet ice to a participating reference laboratory. Participating laboratories included NIHE, the Pasteur Institute, Ho Chi Minh city (IP HoChi Minh); the Pasteur Institute Nha Trang (IPNha Trang); and Tay Nguyen Institute of Hygiene and Epidemiology (TIHE). 1 
Viral isolation
Swabs that were positive for influenza A by RT-PCR were selected for viral isolation, with 100 ll of sample inoculated onto MDCK cells (Madin-Darby canine kidney cellsAmerican Type Culture Collection-ATCC) according to NISS protocols. 1, 5, 7 Viruses were harvested and stored in )80°C, and all isolates from regional laboratories were transferred to the NIC-NIHE for further analysis. 1, 6, 12 All isolates were subtyped using the hemagglutination inhibition assay (HAI) with reference antigens and antisera from the World Health Organization (WHO) reagent kit.
1,6
Molecular characterization
Subtyped influenza A isolates with a minimum of 8 HA unit by HA assay were selected for genetic analysis by sequencing at NIC-NIHE, Hanoi. 6 (Table 2) RNA extraction and Polymerase Chain Reaction (PCR)
RNA extraction was conducted on 140 ll aliquot of each isolate using the Viral RNA extraction kit (Qiagen-US) according to the manufacturer's instructions. The RNA was transcribed to cDNA using the influenza A virus universal primer (Uni 12) AGC AAA AGC AGG as described. 13 The hemagglutinin (HA) gene was amplified with segmentspecific primers. 6, 7, 13 Nucleotide sequencing and phylogenetic analysis
The PCR products were purified with PCR purification kit (Qiagen-US), and sequencing reactions performed with a Big Dye Terminator v 3.1. Cycle sequencing kit (Applied Biosystem, Foster city, CA, USA) according to manufacturer's instructions. Reaction products were resolved on an ABI 3100 automatic DNA sequencer and sequences assembled using DNA star v 8.0. Sequences were aligned with CLUSTAL X for the major coding regions of HA segments. The sequences of influenza A vaccine viruses were included along with HA sequences from neighboring countries: China, Thailand, Hong Kong SAR, Cambodia, and Japan obtained from the influenza virus resource (National Center for Biotechnology information; http:ncbi.nlm.nih. gov ⁄ genomes ⁄ FLU ⁄ FLU.html.). Because the HA1 domain of HA, the major antigenic protein of influenza A viruses, contains all the antigenic sites of HA and is continually under selection pressure driven by the host's immune response, 1130 nucleotides corresponding to the HA1 ⁄ H1 domain and 1115 nucleotides for the HA1 ⁄ H3 domain were used to construct phylogenetic trees by maximum likelihood (ML) method with bootstrap supported values. To quantify amino acid sequence diversity of each lineage, we used MEGA 5 software package and blasted against the NCBI database to determine the closest sequence available for representative strains of each lineage. The clade numbering for nucleotide-based and amino acid-based clustering was somewhat different due to synonymous substitutions at the nucleotide level.
Nucleotide sequence accession numbers
All sequences newly reported in this study have been deposited in the GenBank database under accession numbers JX506656 to JX506727. (Table 2 ). However, some of these amino acid differences are due to egg adaptation seen with the A ⁄ Solomon Islands ⁄ 3 ⁄ 2006 vaccine virus that was not seen in the Vietnamese viruses as they were isolated in MDCK cells. (Fig 3, table 2 ). During the 2005 influenza season, we collected twelve H3N2 isolates and most of them (9 ⁄ 12) were grouped in clade IV, with a small number of isolates (3) Red: WHO vaccine strains Blue : Vietnamese strains Table 2 ).
Results
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Discussion
We Larger genetic variation of HA sequences were observed in A ⁄ H3N2 viruses, with six clades being detected during the study period. This is consistent with the known faster evolution of H3N2 viruses compared with H1N1 or influenza B viruses. 15 Our results showed that the WHO vaccine strain recommended for Northern and Southern Hemi- Although analysis of the HA gene does provide some indication on the emergence of antigenically divergent strains, inferences about the protection afforded by WHO recommended influenza vaccine strains in Vietnam are limited by the lack of antigenic data, due to the unavailability of essential reagents in the time period prior to participating in the GISRS (2001) (2002) (2003) (2004) (2005) . Genetic data are, however, useful because some genetic changes can generate significant antigenic changes that drive the evolution of influenza. 16 Full antigenic characterization of viruses from Vietnam and other South East Asian countries is required to ensure that vaccine strains selected by WHO will provide protection in these areas. Such characterization is particularly important given that H3N2 virus may evolve and emerge from an East and Southeast Asia network, 15 the large number of people living in this region, and the more complex epidemiology compared with temperate regions. Therefore, sharing materials, such as epidemiological data and representative isolates, from a variety of countries has important implications for influenza vaccine strain selection and the optimal implementation of influenza vaccination programs.
Vietnam is located in the Northern Hemisphere and is in close in proximity to southern China, which has been considered an epicenter of human influenza outbreaks. 17 However, the circulation of seasonal influenza A virus often peaks between May and November in Vietnam, 1 similar to Southern Hemisphere epidemics, 15 and our finding suggest that Vietnamese H3N2 isolates were more similar to WHO Southern Hemisphere vaccine strains in recent years. Thus, strain selection for Southern Hemisphere countries needs to consider strains circulating in Vietnam, and vice versa.
Currently, Vietnam lacks a national policy for influenza vaccination as there is insufficient data on the burden of disease and the local epidemiology and virology. Our results provide information on the HA gene that reveals evolution of the virus that might be expected to lead to antigenic change. Complete genome analysis and serological testing (HAI) of influenza A viruses will be necessary to obtain a more comprehensive picture of virus evolution and to guide vaccine strategy in the future in Vietnam.
